Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dow, Eli Lilly
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and currently trading at $912.00. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,
Eli Lilly & Co. stock underperforms Tuesday when compared to competitors
Shares of Eli Lilly & Co. LLY slipped 1.88% to $906.18 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.03% to 5,634.58 and the Dow Jones Industrial Average DJIA falling 0.
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years
Eli Lilly LLY has outperformed the market over the past 20 years by 5.71% on an annualized basis producing an average annual return of 13.92%. Currently, Eli Lilly has a market capitalization of $810.81 billion.
59m
Eli Lilly: I Admit Defeat As I Understated Its Growth Prospects (Upgrade)
Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...
24/7 Wall St
1d
Prediction: This Will Be the Biggest Pharma Stock in 10 Years
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...
1d
1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025
Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.
1d
Eli Lilly urges court to toss $183 mln Medicaid fraud judgment
Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...
1d
on MSN
ResMed slips as Wolfe downgrades on GLP-1 threat from Lilly
ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...
2d
on MSN
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
5d
on MSN
World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna
Bridgewater Associates slashed a stake in Apple, halved its Lilly investment, doubled down on Microsoft, and bought Moderna ...
3d
Unpacking the Latest Options Trading Trends in Eli Lilly
Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Eli Lilly with a target price of $1100 ...
3d
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback